- Home
- EVN vs TKNO Comparison
EVN vs TKNO Comparison
Compare EVN & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVN
- TKNO
- Stock Information
- Founded
- EVN 1998
- TKNO 1996
- Country
- EVN United States
- TKNO United States
- Employees
- EVN N/A
- TKNO N/A
- Industry
- EVN Investment Bankers/Brokers/Service
- TKNO Medicinal Chemicals and Botanical Products
- Sector
- EVN Finance
- TKNO Health Care
- Exchange
- EVN Nasdaq
- TKNO Nasdaq
- Market Cap
- EVN 410.0M
- TKNO 430.2M
- IPO Year
- EVN N/A
- TKNO 2021
- Fundamental
- Price
- EVN $10.35
- TKNO $5.19
- Analyst Decision
- EVN
- TKNO Buy
- Analyst Count
- EVN 0
- TKNO 1
- Target Price
- EVN N/A
- TKNO $5.00
- AVG Volume (30 Days)
- EVN 101.2K
- TKNO 556.8K
- Earning Date
- EVN 01-01-0001
- TKNO 03-04-2025
- Dividend Yield
- EVN 4.78%
- TKNO N/A
- EPS Growth
- EVN N/A
- TKNO N/A
- EPS
- EVN 0.34
- TKNO N/A
- Revenue
- EVN N/A
- TKNO $37,745,000.00
- Revenue This Year
- EVN N/A
- TKNO $12.70
- Revenue Next Year
- EVN N/A
- TKNO $19.79
- P/E Ratio
- EVN $29.94
- TKNO N/A
- Revenue Growth
- EVN N/A
- TKNO 2.89
- 52 Week Low
- EVN $8.64
- TKNO $1.16
- 52 Week High
- EVN $10.45
- TKNO $10.37
- Technical
- Relative Strength Index (RSI)
- EVN 44.77
- TKNO 36.06
- Support Level
- EVN $10.18
- TKNO $4.79
- Resistance Level
- EVN $10.69
- TKNO $5.69
- Average True Range (ATR)
- EVN 0.14
- TKNO 0.43
- MACD
- EVN -0.02
- TKNO 0.04
- Stochastic Oscillator
- EVN 32.35
- TKNO 24.33
About EVN Eaton Vance Municipal Income Trust
Eaton Vance Municipal Income Trust is a United States-based diversified, closed-end management investment company. Its investment objective is to provide current income exempt from regular federal income tax. The trust's portfolio of investments majorly consists of debt instruments of governments, municipal organizations the interest on which is exempt from regular federal income tax and has also some exposure to corporate bonds and other instruments.
About TKNO Alpha Teknova Inc.
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its product offerings include pre-poured media plates for cell growth and cloning, liquid cell culture media and supplements for cellular expansion, and molecular biology reagents for sample manipulation, resuspension, and purification. It derives maximum revenue from United States.